Your search returned 2 results.

Results
	1.	Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study).[Erratum appears in Diabetes Obes Metab. 2016 Sep;18(9):952; PMID: 27546838] MedStar authors: Aroda, Vanita R PMID: 26990378 Year: 2016 Citation: Diabetes, Obesity & Metabolism. 18(7):663-70, 2016 Jul Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Andersen TH, Aroda VR, Bailey TS, Cariou B, Kumar S, Leiter LA, Philis-Tsimikas A, Raskin P, Zacho J DOI: https://dx.doi.org/10.1111/dom.12661 Add to cart (remove)
	2.	Neuropsychiatric safety with liraglutide 3.0mg for weight management: results from randomized controlled phase 2 and 3a trials. MedStar authors: Aroda, Vanita R PMID: 28386912 Year: 2017 Citation: Diabetes, Obesity & Metabolism. 19(11):1529-1536, 2017 Nov. Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Aroda VR, Astrup A, Brett J, Cancino A, Kushner R, Lau DC, O'Neil PM, Satiety and Clinical Adiposity - Liraglutide Evidence in individuals with and without diabetes (SCALE) study groups, Wadden TA, Wilding JP DOI: https://dx.doi.org/10.1111/dom.12963 Add to cart (remove)

Refine your search